Ysios invests in French cardiac device maker CorWave

, , ,
Integral service around a transaction
BY : Diego GutiérrezNovember Thu, 2016
A month after announcing the closing of its second fund, Ysios has invested in French company CorWave. Thus entering a market that is moving a lot of money, cardiac assistance devices. This round is the first French investment by Ysios, which in addition to Spain has invested in the US, the Netherlands, Belgium, Switzerland and Sweden.



Ysios buys CorWave

Ysios has participated in the second round closed by Corware, a medical technology company developing innovative cardiac devices. The €15.5M round was led by Novo Seeds. Ysios has invested €3.3M in the company becoming a major shareholder and will have a seat on the board of directors.

CorWave, founded in 2012, had already made an investment round in 2013 and counts among its shareholders Sofinnova Partners, Bpifrance, Seventure and Medtronic.

The investment is high-risk, as Corwave's research is still in the pre-clinical phase. Even so, forecasts suggest that, if all the remaining stages are successfully completed, the technology could be on the market between 2018 and 2019. Although the investment has now been 3.3 million euros, Ysios is reserving up to 10 million euros for the company.

About Corwave

CorWave develops innovative cardiac assist devices. Its technology is protected by seven patent families. They stem from more than 10 years of research led by AMS R&D and academic laboratories. The company was founded in 2011 by Paris-based incubator MD Start and won the World Innovation Challenge in 2016. The company employs a team of 20 engineers and researchers in the centre of Paris, in the Pepiniere Paris Sante Cochin

The heart failure market

The heart failure market is a market in which a lot of research and money is being invested. Proof of this are the acquisitions made in the last two years in the sector by technology giants, who want to offer solutions in this niche market.

So St-Jude-Abbot bought in July 2015 for $3,4B Thoratec, one of the world leaders in heart pumps, which in April of the same year had won FDA approval for a new product. This company went public on Nasqad in 1996 and in 2014 acquired the company Cardiovascular Apica by $75M.

Medtronicthe second largest medical device manufacturer, has also recently acquired HeartWare for $1.2M. HeartWare specialises in the manufacture of replacement heart valves.
If you want to make a buy or a selling a company, you need financing or you have a R&D projectAbra-invest has a team of experts in alternative financing at your disposal. Call +34 946424142 or fill in the contact form.

The M&A Professionals

Meet our services



Do you want to be up to date?


Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?